Showing results (11-20 of 587) with videos related to
Sort By:
Pageof 59
Clinical and Translational Gastroenterology|July 14, 2017
Fistulizing Crohn's DiseaseMichael Scharl, Gerhard Rogler, Luc BiedermannCurrent Drug Targets|April 30, 2013
Review: new anti-cytokines for IBD: what is in the pipeline?Michael Scharl, Stephan R Vavricka, Gerhard RoglerUnited European Gastroenterology Journal|August 19, 2016
The two sides of the coin: Similarities and differences in the pathomechanisms of fistulas and stricture formations in irritable bowel diseaseMichael Scharl, Ramona S Bruckner, Gerhard RoglerDigestive Diseases (Basel, Switzerland)|June 28, 2014
Crohn's disease: loss of tolerance or a disorder of autophagy?Marianne R Spalinger, Gerhard Rogler, Michael ScharlInflammatory Intestinal Diseases|July 19, 2018
The Efficacy and Safety of Golimumab as Third- or Fourth-Line Anti-TNF Therapy in Patients with Refractory Crohn's Disease: A Case SeriesLinda Russi, Michael Scharl, Gerhard Rogler, et al.Current Drug Targets|September 9, 2014
Biologics for extraintestinal manifestations of IBDStephan R Vavricka, Michael Scharl, Martin Gubler, et al.Digestion|September 15, 2010
Dying in yoghurt: the number of living bacteria in probiotic yoghurt decreases under exposure to room temperatureMichael Scharl, Steffen Geisel, Stephan R Vavricka, et al.Drugs|February 18, 2014
Steroid use in Crohn's diseaseStephan R Vavricka, Alain M Schoepfer, Michael Scharl, et al.World Journal of Gastroenterology|January 27, 2016
Protein tyrosine phosphatase non-receptor type 2 and inflammatory bowel diseaseMarianne R Spalinger, Declan F McCole, Gerhard Rogler, et al.Inflammatory Bowel Diseases|January 13, 2015
Role of protein tyrosine phosphatases in regulating the immune system: implications for chronic intestinal inflammationMarianne R Spalinger, Declan F McCole, Gerhard Rogler, et al.Pageof 59